Funding
Growth investment · Healthtech

Neurent Medical secures $25m growth investment

Claret Capital Partners backed Neurent’s commercial expansion of NEUROMARK.

Updated Oct 16, 2026By RoundOS Funding desk

The $25m investment will support commercial expansion, sales and marketing, and the company’s balance sheet for future growth.

The financing follows a separate €62.5m Series C recorded in February. NEUROMARK targets hyperactive posterior nasal nerves with impedance-controlled radiofrequency energy to treat chronic rhinitis.

Use of funds

Commercial expansion

Sales and marketing

Fund the balance sheet and future growth

Funding history

Growth investment · This round$25M
Series C€62.5M

Sources

  1. Just a moment...finsmes.com · Sep 9, 2026
  2. Neurent Medicalprojectstartups.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026
CureBay

CureBay operates a hybrid healthcare network for rural and underserved communities in India.

~₹1BPre-Series C · Oct 22, 2026
iCUREX

Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.

¥140MSeries A first close: equity and debt · Oct 22, 2026

Related